644 related articles for article (PubMed ID: 9950596)
1. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
Romanowski EG; Bartels SP; Gordon YJ
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596
[TBL] [Abstract][Full Text] [Related]
2. HPMPC, a broad-spectrum topical antiviral agent, inhibits herpes simplex virus type 1 replication and promotes healing of dendritic keratitis in the New Zealand rabbit ocular model.
Gordon YJ; Romanowski EG; Araullo-Cruz T
Cornea; 1994 Nov; 13(6):516-20. PubMed ID: 7842711
[TBL] [Abstract][Full Text] [Related]
3. Trifluridine, cidofovir, and penciclovir in the treatment of experimental herpetic keratitis.
Kaufman HE; Varnell ED; Thompson HW
Arch Ophthalmol; 1998 Jun; 116(6):777-80. PubMed ID: 9639447
[TBL] [Abstract][Full Text] [Related]
4. Cidofovir and experimental herpetic stromal disease.
Kaufman HE; Varnell ED; Thompson HW
Arch Ophthalmol; 1999 Jul; 117(7):925-8. PubMed ID: 10408458
[TBL] [Abstract][Full Text] [Related]
5. Effects of diclofenac or ketorolac on the inhibitory activity of cidofovir in the Ad5/NZW rabbit model.
Romanowski EG; Gordon YJ
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):158-62. PubMed ID: 11133861
[TBL] [Abstract][Full Text] [Related]
6. Topical corticosteroids reverse the antiviral effect of topical cidofovir in the Ad5-inoculated New Zealand rabbit ocular model.
Romanowski EG; Araullo-Cruz T; Gordon YJ
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):253-7. PubMed ID: 9019458
[TBL] [Abstract][Full Text] [Related]
7. N-chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5/NZW rabbit ocular model.
Romanowski EG; Yates KA; Teuchner B; Nagl M; Irschick EU; Gordon YJ
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2021-6. PubMed ID: 16639011
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of topical cidofovir on multiple adenoviral serotypes in the New Zealand rabbit ocular model.
Romanowski EG; Gordon YJ
Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):460-3. PubMed ID: 10670476
[TBL] [Abstract][Full Text] [Related]
9. Trifluridine decreases ocular HSV-1 recovery, but not herpetic lesions after timolol iontophoresis.
Rootman DS; Hill JM; Haruta Y; Reidy JJ; Kaufman HE
Invest Ophthalmol Vis Sci; 1989 Apr; 30(4):678-83. PubMed ID: 2539342
[TBL] [Abstract][Full Text] [Related]
10. Management of acyclovir-resistant herpes simplex virus.
Chilukuri S; Rosen T
Dermatol Clin; 2003 Apr; 21(2):311-20. PubMed ID: 12757254
[TBL] [Abstract][Full Text] [Related]
11. (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis.
Maudgal PC; De Clercq E
Invest Ophthalmol Vis Sci; 1991 May; 32(6):1816-20. PubMed ID: 1851733
[TBL] [Abstract][Full Text] [Related]
12. Effect of oral valaciclovir on herpetic keratitis.
Higaki S; Itahashi M; Deai T; Fukuda M; Shimomura Y
Cornea; 2006 Dec; 25(10 Suppl 1):S64-7. PubMed ID: 17001196
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the antiherpetic activity of acyclovir in rabbits.
Trousdale MD; Nesburn AB
Am J Med; 1982 Jul; 73(1A):155-60. PubMed ID: 6285707
[TBL] [Abstract][Full Text] [Related]
14. The antiviral resistance and replication of cidofovir-resistant adenovirus variants in the New Zealand White rabbit ocular model.
Romanowski EG; Gordon YJ; Araullo-Cruz T; Yates KA; Kinchington PR
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1812-5. PubMed ID: 11431446
[TBL] [Abstract][Full Text] [Related]
15. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of acyclovir-resistant herpetic keratitis and experimental studies of isolates.
Yao YF; Inoue Y; Kase T; Uchihori Y; Mori Y; Ohashi Y
Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S126-32. PubMed ID: 8871163
[TBL] [Abstract][Full Text] [Related]
17. Effect of Azone upon the in vivo antiviral efficacy of cidofovir or acyclovir topical formulations in treatment/prevention of cutaneous HSV-1 infections and its correlation with skin target site free drug concentration in hairless mice.
Afouna MI; Fincher TK; Zaghloul AA; Reddy IK
Int J Pharm; 2003 Mar; 253(1-2):159-68. PubMed ID: 12593946
[TBL] [Abstract][Full Text] [Related]
18. Effect of topical acyclovir therapy on experimental herpes simplex keratouveitis.
Maudgal PC; Vrijghem JC; Molemans M; Missotten L
Arch Ophthalmol; 1985 Sep; 103(9):1389-92. PubMed ID: 3929753
[TBL] [Abstract][Full Text] [Related]
19. The treatment of herpes simplex virus epithelial keratitis.
Wilhelmus KR
Trans Am Ophthalmol Soc; 2000; 98():505-32. PubMed ID: 11190039
[TBL] [Abstract][Full Text] [Related]
20. Influence of the treatment protocol upon the in vivo efficacy of cidofovir (HPMPC) and of acyclovir (ACV) formulations in topical treatment of cutaneous HSV-1 infection in hairless mice.
Afouna MI; Mehta SC; Ghanem AH; Higuchi WI; Kern ER; DeClercq E; El-Shattawy HH
J Pharm Sci; 1999 May; 88(5):530-4. PubMed ID: 10229644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
